Stay Cool with Divigel® The #1 prescribed transdermal estrogen gel.1
Divigel® is FDA-approved to treat moderate to severe vasomotor symptoms (hot flashes and night sweats) due to menopause.
Proven Relief From Hot Flashes and Night Sweats
- Eliminated nearly 90% of hot flashes by 12 weeks with 1 mg/day.2
- Reduced hot flashes by nearly HALF in as little as 2 weeks (1 mg/day).2
- Comes in five dose strengths, including the lowest FDA approved dose.3
- At the lowest dose (0.25 mg/day) Divigel® eliminated about 70% of hot flashes in 12 weeks.2
The FDA recommends the lowest effective dose with any estrogen therapy.3,4 Only Divigel® offers the lowest dose of topical estrogen gel or spray available for hot flashes (0.25 mg/day estradiol)3
Use estrogen-alone, or in combination with progestin, at the lowest effective dose and for the shortest duration consistent with treatment goals and risks for the individual woman.
Cool, Discreet Gel
- Divigel® is a gel that leaves no sticky residue.
- It’s invisible and odorless when dry. Nobody knows you’re wearing it.
- It’s a concentrated estradiol gel, so only a small amount is needed for big relief.
Easy to Use and Convenient
- A small amount of Divigel® is applied once daily to the upper thigh.
- The gel comes in small, discreet, portable packets that are easy to use at home and great for travel.
- Premeasured, daily packets ensure precise, accurate dosing.
- Divigel® becomes part of your daily personal care routine.
DELIVERED THROUGH THE SKIN
Although the clinical significance has not been determined, estradiol from Divigel® does not undergo first pass metabolism.
DIVIGEL® TOPICAL GEL
1. This information is an estimate derived from the use of information under license from the following IQVIA information service: NPA™, for the period 2019. IQVIA expressly reserves all rights, including rights of copying, distribution and republication.
2. Hedrick RE, Ackerman RT, Koltun WD, Halvorsen MB, Lambrecht LJ. Transdermal estradiol gel 0.1% for the treatment of vasomotor symptoms in postmenopausal women. Menopause. 2009;16(1):132-140.
3. Orange Book: Approved Drug Products with Therapeutic equivalence Evaluations. U.S. Food & Drug Administration. Accessed February 13, 2020. https://www.accessdata.fda.gov/scripts/cder/ob/search_product.cfm
4. US Food and Drug Administration. Menopause. Updated August 22, 2019. Accessed February 13, 2020. https://www.fda.gov/consumers/womens-health-topics/menopause